Abliva

About Amel Karaa, MD

Amel Karaa, MD, is an internist and clinical geneticist by training and specializes in treating patients with complex medical conditions including primary mitochondrial diseases at the Massachusetts General Hospital in Boston. Dr. Karaa is a clinical researcher and a clinical trialist who has led and been involved in several national and international mitochondrial disease clinical trials at different stages of drug development.
 
Dr. Karaa is the 2013 United mitochondrial disease foundation (UMDF) fellow, a site investigator for the NIH North American Mitochondrial Disease Consortium (NAMDC), one of the Founders and Director of the Mitochondrial Care Network (MCN) overseeing mitochondrial disease expert centers in the US, Chair of the scientific/medical board of the UMDF, immediate past-president of the Mitochondrial Medicine society (MMS) and has more recently focused on developing a US wide clinical trial consortium for primary mitochondrial disorders; The Translational Research Advancing Therapy in Mitochondrial Diseases Consortium (TREAT MITO).